WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry. The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable. “The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release. |
Kim Kardashian sparks shock cosmetic surgery theory after expert spots key detail at Met GalaRussian offensive on Kharkiv forces some 1,700 civilians to fleeRevealed: King Charles met David Beckham privately while Prince Harry was in BritainFine dining, at a new high. A MichelinDowns scores late to keep Cologne up and defer Bundesliga relegation decisions to final daySmarter vehicles could mean big changes for the traffic lightArizona Cardinals agree to terms on 1Love Is Blind stars Zack and Bliss welcome their first child togetherFirst GuizhouTeresa Giudice recalls meeting Taylor Swift in VIP area at Coachella